BioSpace News Archive

Hummingbird Bioscience, a data-driven precision biotherapeutics company discovering and developing transformative biologic medicines for hard-to-treat diseases, announced an upcoming poster presentation at IMMUNOLOGY2023™.

VanDeMark Chemical, Inc., a leading global producer of life science chemistries, announced the appointment of Dr. Boudewijn van Lent as President and CEO, effective immediately.

KalVista Pharmaceuticals, Inc. announced that it made two oral presentations and one poster presentation at the 13th C1-inhibitor Deficiency & Angioedema Workshop in Budapest, Hungary.

Zomedica Corp., announced it has exercised its option to move forward with the acquisition of Structured Monitoring Products, Inc., the makers of VetGuardian™ zero-touch vital signs remote monitoring system, at a previously negotiated purchase price.

BioNTech SE reported financial results for the three months ended March 31, 2023, and provided an update on its corporate progress.

Pharvaris reported financial results for the first quarter ended March 31, 2023 and provided a business update.

Mallinckrodt plc, a global specialty pharmaceutical company, announced the presentation of results from two clinical studies for adults with hepatorenal syndrome with rapid reduction in kidney function1 treated with TERLIVAZ® for injection at Digestive Disease Week® 2023, taking place in Chicago, Ill.

ANI Pharmaceuticals, Inc. announced business highlights and financial results for the three months ended March 31, 2023.

BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage company focused on stem cell-based therapies, today announced that it has signed a clinical trial agreement with Northwell Health, New York State’s largest health care provider and private employer, and Northwell’s Feinstein Institutes for Medical Research.

Athira Pharma, Inc., a late clinical-stage biopharmaceutical company focused on developing small molecules to restore neuronal health and slow neurodegeneration, announced that it will participate in the following upcoming investor conferences.